Optune had multiple trial results published in JAMA. Has many more trial publications than NWBO and is far ahead in other indications, such as it's recent NSCLC results that caused a considerable share price jump, unlike NWBO's results that seem to have had virtually no positive effect.
Market Data 
Markets 
AI
